Literature DB >> 23722085

High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.

Shanmugam Saravanan1, Vidya Madhavan, Vijayakumar Velu, Kailapuri G Murugavel, Greer Waldrop, Sunil S Solomon, Pachamuthu Balakrishnan, Nagalingeswaran Kumarasamy, Davey M Smith, Kenneth H Mayer, Suniti Solomon, Sadras P Thyagarajan.   

Abstract

We conducted a study to investigate HIV and hepatitis delta virus (HDV) coinfection among patients with chronic hepatitis B virus (HBV) infection and the triple infection's (HIV/HBV/HDV) clinical implications in India, an intermediate HBV endemic region, with an estimated HIV-positive population of 2.5 million. A total of 450 patients (men: 270; women: 180) with chronic HBV infections and 135 healthy volunteers were screened for HIV and HDV. The incidence of the triple infection was low (4 [0.8%]) compared with dual infections of HIV-1/HBV (7 [1.5%]) and HBV/HDV (22[4.8%]). Among 21- to 40-year-olds, HBV/HDV coinfection (45.8%) and HBV/HDV/HIV-1 triple infection was predominant (75%). Among 11 patients coinfected with HIV-1/HBV, 4 (36%) were tri-infected and were also associated with chronic hepatitis and cirrhosis. The HDV coinfection was higher among patients coinfected with HBV/HIV-1, despite the declining trend in HDV infection among HIV-negative patients, as previously reported. Thus, it is important to assess the impact of HIV, chronic HBV, and HDV tri-infection in India.

Entities:  

Keywords:  coinfection in India; hepatitis B virus (HBV); hepatitis delta virus (HDV); human immunodeficiency virus (HIV)

Mesh:

Year:  2013        PMID: 23722085      PMCID: PMC4114572          DOI: 10.1177/2325957413488166

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  30 in total

1.  Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group.

Authors:  T Stroffolini; L Ferrigno; L Cialdea; R Catapano; F Palumbo; F Novaco; A Moiraghi; C Galanti; R Bernacchia; A Mele
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

2.  Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.

Authors:  L Monno; G Angarano; T Santantonio; M Milella; S Carbonara; J R Fiore; C Fico; G Pastore
Journal:  J Med Virol       Date:  1991-07       Impact factor: 2.327

3.  Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.

Authors:  J L Casey; G A Niro; R E Engle; A Vega; H Gomez; M McCarthy; D M Watts; K C Hyams; J L Gerin
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.

Authors:  C Housset; S Pol; F Carnot; F Dubois; B Nalpas; B Housset; P Berthelot; C Brechot
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

5.  Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen.

Authors:  S M Cole; E J Gowans; T B Macnaughton; P D Hall; C J Burrell
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

6.  Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.

Authors:  D M Novick; P Farci; T S Croxson; M B Taylor; C W Schneebaum; M E Lai; N Bach; R T Senie; A M Gelb; M J Kreek
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

7.  Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.

Authors:  P J Chen; D S Chen; C R Chen; Y Y Chen; H M Chen; M Y Lai; J L Sung
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

Review 8.  Epidemiology of hepatitis B virus infection in India.

Authors:  B N Tandon; S K Acharya; A Tandon
Journal:  Gut       Date:  1996       Impact factor: 23.059

9.  Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.

Authors:  S Pol; L Wesenfelder; F Dubois; P Roingeard; F Carnot; F Driss; C Brechot; A Goudeau; P Berthelot
Journal:  J Viral Hepat       Date:  1994       Impact factor: 3.728

10.  Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?

Authors:  M Buti; R Jardi; H Allende; M Cotrina; F Rodriguez; L Viladomiu; R Esteban; J Guardia
Journal:  J Med Virol       Date:  1996-05       Impact factor: 2.327

View more
  7 in total

1.  Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV.

Authors:  T R Dinesha; J Boobalan; S Sivamalar; D Subashini; S S Solomon; K G Murugavel; P Balakrishnan; D M Smith; S Saravanan
Journal:  J Viral Hepat       Date:  2018-02-19       Impact factor: 3.728

Review 2.  Viral hepatitis and human immunodeficiency virus co-infections in Asia.

Authors:  Takako Utsumi; Maria I Lusida
Journal:  World J Virol       Date:  2015-05-12

3.  Prevalence of Hepatitis Delta Virus Infection among Hepatitis B Virus-Infected and Exposed Patients.

Authors:  Krithiga Ramachandran; Reshu Agarwal; Manoj Kumar Sharma; Vikram Bhatia; Ekta Gupta
Journal:  J Glob Infect Dis       Date:  2020-11-30

4.  Control of HBV infection in HIV/HBV co-infected patients treated with antiretroviral therapy - experience of Lodz Centre.

Authors:  Ewelina Wlazłowska; Anna Piekarska; Juliusz Kamerys; Kamila Wójcik-Cichy; Elżbieta Jabłonowska
Journal:  Clin Exp Hepatol       Date:  2022-03-23

5.  Prevalence and risk factors of Hepatitis D virus antibody among asymptomatic carriers of Hepatitis B virus: a community survey.

Authors:  Uchenna C Okonkwo; Henry C Okpara; Kenneth Inaku; Tony M Aluka; Evaristus S Chukwudike; Yeonun Ogarekpe; Emin J Emin; Osim Hodo; Akaninyene A Otu
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

Review 6.  Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery.

Authors:  Mazen Noureddin; Robert Gish
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 7.  Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic.

Authors:  Caterina Sagnelli; Mariantonietta Pisaturo; Caterina Curatolo; Alessio Vinicio Codella; Nicola Coppola; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.